Leonardo DRS, Inc.
DRS Nasdaq Search, Detection, Navigation, Guidance, Aeronautical Sys Financials FY2019βFY2025
What Leonardo DRS, Inc. does
No business description yet.
- Legal name
- Leonardo DRS, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001833756-26-000013
0001833756
Revenue and margins
Leonardo DRS, Inc. had $3.6B of revenue in fiscal 2025, up 12.8% on the year before.
Net income and earnings per share
From fiscal 2019 to 2025, diluted EPS grew 12.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $227M in fiscal 2025, 6.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Leonardo DRS, Inc. returned $35.0M to shareholders in fiscal 2025, 15% of free cash flow. The diluted share count rose 0.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Leonardo DRS, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $240M | $306M | $467M | $598M | $647M |
| Debt incl. finance leases | $569M | $567M | $600M | $483M | $459M |
| Net debt / EBITDA | 1.1x | 0.4x | 0.4x | β0.3x | β0.4x |
| Debt / equity | 0.3x | 0.2x | 0.2x | 0.1x | 0.1x |
| Interest coverage | 6.7x | 16.5x | 6.4x | 14.0x | β |
| Current ratio | 1.4x | 1.6x | 1.8x | 1.9x | 1.9x |
| Quick ratio | 1.2x | 1.3x | 1.5x | 1.6x | 1.6x |
| Total assets | $3.1B | $3.7B | $3.9B | $4.2B | $4.5B |
| Total liabilities | $1.5B | $1.6B | $1.6B | $1.6B | $1.8B |
| Shareholders' equity | $1.6B | $2.1B | $2.3B | $2.6B | $2.7B |
| Net debt (β = net cash) | $329M | $261M | $133M | β$115M | β$188M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 8 / 9 | 6 / 9 | 5 / 9 | 7 / 9 | 7 / 9 |
| Accruals ratio | β | β1.4% | β0.8% | 11.0% | β1.0% | β1.4% | β2.0% |
| Altman Z'' | β | β1.43 | β0.66 | 1.02 | 1.00 | 1.74 | 2.07 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $2.7B | $2.8B | $2.9B | $2.7B | $2.8B | $3.2B | $3.6B |
| Gross profit | $459M | $494M | $547M | $575M | $648M | $736M | $869M |
| Research and development | $31.0M | $41.0M | $48.0M | $58.0M | $82.0M | $92.0M | $129M |
| Operating income | $163M | $181M | $236M | $561M | $231M | $293M | $348M |
| Interest expense | $65.0M | $64.0M | $35.0M | $34.0M | $36.0M | $21.0M | β |
| Pretax income | $95.0M | $112M | $200M | $525M | $192M | $264M | $336M |
| Income tax | $20.0M | $27.0M | $46.0M | $120M | $24.0M | $51.0M | $58.0M |
| Net income | $75.0M | $85.0M | $154M | $405M | $168M | $213M | $278M |
| Net income to common | β | $85.0M | $154M | $405M | $168M | $213M | $278M |
| Diluted EPS | $0.52 | $0.40 | $0.73 | $1.88 | $0.64 | $0.80 | $1.03 |
| Diluted shares | β | 0.21B | 0.21B | 0.22B | 0.26B | 0.27B | 0.27B |
| Cash flow | |||||||
| Cash from operations | $157M | $125M | $178M | $33.0M | $205M | $271M | $366M |
| Capital expenditure | $55.0M | $56.0M | $60.0M | $65.0M | $60.0M | $85.0M | $139M |
| Free cash flow | $102M | $69.0M | $118M | β$32.0M | $145M | $186M | $227M |
| Depreciation and amortization | $51.0M | $53.0M | $58.0M | $65.0M | $85.0M | $91.0M | $93.0M |
| Stock-based compensation | β | $0.0M | $0.0M | $5.0M | $17.0M | $22.0M | $32.0M |
| Acquisitions | $4.0M | $0.0M | $14.0M | β$19.0M | $0.0M | $0.0M | β |
| Share buybacks | β | β | β | β | $0.0M | $0.0M | $35.0M |
| Dividends paid | β | $0.0M | $0.0M | $396M | $0.0M | $0.0M | β |
| Dividends and buybacks | β | $0.0M | $0.0M | $396M | $0.0M | $0.0M | $35.0M |
| Balance sheet | |||||||
| Cash and short-term investments | $85.0M | $61.0M | $240M | $306M | $467M | $598M | $647M |
| Total debt | β | $401M | $408M | $406M | $442M | $370M | $353M |
| Finance lease liabilities | β | $163M | $161M | $161M | $158M | $113M | $106M |
| Current assets | β | $1.3B | $1.4B | $1.7B | $1.9B | $2.2B | $2.3B |
| Current liabilities | β | $975M | $989M | $1.0B | $1.1B | $1.1B | $1.2B |
| Inventory | β | $247M | $205M | $319M | $329M | $358M | $352M |
| Goodwill | $1.1B | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | $1.2B |
| Intangible assets | β | $60.0M | $52.0M | $172M | $151M | $132M | $112M |
| Total assets | β | $3.0B | $3.1B | $3.7B | $3.9B | $4.2B | $4.5B |
| Total liabilities | β | $1.5B | $1.5B | $1.6B | $1.6B | $1.6B | $1.8B |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $1.0B | $1.4B | $1.6B | $2.1B | $2.3B | $2.6B | $2.7B |
| Margins | |||||||
| Gross margin | 16.9% | 17.8% | 19.0% | 21.4% | 22.9% | 22.8% | 23.8% |
| Operating margin | 6.0% | 6.5% | 8.2% | 20.8% | 8.2% | 9.1% | 9.5% |
| EBITDA margin | 7.9% | 8.4% | 10.2% | 23.2% | 11.2% | 11.9% | 12.1% |
| Net margin | 2.8% | 3.1% | 5.3% | 15.0% | 5.9% | 6.6% | 7.6% |
| FCF margin | 3.8% | 2.5% | 4.1% | β1.2% | 5.1% | 5.8% | 6.2% |
| Returns | |||||||
| Return on capital | β | 7.8% | 10.3% | 19.4% | 8.8% | 10.2% | 11.8% |
| Return on capital employed | β | 9.1% | 11.3% | 21.3% | 8.1% | 9.6% | 10.7% |
| Return on equity | 7.4% | 7.0% | 10.2% | 21.8% | 7.5% | 8.7% | 10.5% |
| Return on assets | β | 2.9% | 5.1% | 12.0% | 4.4% | 5.3% | 6.4% |
| Return on tangible equity | β | 27.4% | 32.8% | 56.3% | 17.9% | 17.9% | 20.1% |
| Growth | |||||||
| Revenue growth | β | 2.4% | 3.6% | β6.5% | 4.9% | 14.4% | 12.8% |
| Net income growth | β | 13.3% | 81.2% | 163.0% | β58.5% | 26.8% | 30.5% |
| EPS growth | β | β23.1% | 82.5% | 157.5% | β66.0% | 25.0% | 28.8% |
| FCF growth | β | β32.4% | 71.0% | β127.1% | β | 28.3% | 22.0% |
| Share count change | β | β | 0.0% | 2.4% | 22.8% | 1.3% | 0.4% |
| Financial health | |||||||
| Net debt / EBITDA | β | 2.1x | 1.1x | 0.4x | 0.4x | β0.3x | β0.4x |
| Debt / equity | β | 0.3x | 0.3x | 0.2x | 0.2x | 0.1x | 0.1x |
| Interest coverage | 2.5x | 2.8x | 6.7x | 16.5x | 6.4x | 14.0x | β |
| Current ratio | β | 1.3x | 1.4x | 1.6x | 1.8x | 1.9x | 1.9x |
| Quick ratio | β | 1.0x | 1.2x | 1.3x | 1.5x | 1.6x | 1.6x |
| Capital allocation | |||||||
| Capex / revenue | 2.0% | 2.0% | 2.1% | 2.4% | 2.1% | 2.6% | 3.8% |
| Stock comp / revenue | β | 0.0% | 0.0% | 0.2% | 0.6% | 0.7% | 0.9% |
| Payouts / FCF | β | 0.0% | 0.0% | β | 0.0% | 0.0% | 15.4% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 8.0 | 6.0 | 5.0 | 7.0 | 7.0 |
| Altman Z'' | β | β1.4 | β0.7 | 1.0 | 1.0 | 1.7 | 2.1 |
| Accruals ratio | β | β1.4% | β0.8% | 11.0% | β1.0% | β1.4% | β2.0% |
Source: SEC EDGAR XBRL filings (CIK 0001833756). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.